Hikma Pharmaceuticals PLC
HKMPY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $6,176 | $5,517 | $5,322 | $5,057 |
| - Cash | $236 | $188 | $236 | $205 |
| + Debt | $1,558 | $1,306 | $1,276 | $1,191 |
| Enterprise Value | $7,498 | $6,635 | $6,362 | $6,043 |
| Revenue | $1,658 | $1,558 | $1,569 | $1,436 |
| % Growth | 6.4% | -0.7% | 9.2% | – |
| Gross Profit | $725 | $610 | $756 | $623 |
| % Margin | 43.7% | 39.1% | 48.2% | 43.4% |
| EBITDA | $476 | $309 | $427 | $214 |
| % Margin | 28.7% | 19.8% | 27.2% | 14.9% |
| Net Income | $238 | $132 | $226 | $59 |
| % Margin | 14.4% | 8.5% | 14.4% | 4.1% |
| EPS Diluted | 2.14 | 1.18 | 2.02 | 0.52 |
| % Growth | 81.4% | -41.6% | 288.5% | – |
| Operating Cash Flow | $161 | $319 | $198 | $343 |
| Capital Expenditures | -$68 | -$94 | -$69 | -$95 |
| Free Cash Flow | $93 | $225 | $129 | $247 |